What it is
Dihexa is an angiotensin IV analog — a lab-made peptide discussed for memory and for the growth of synaptic connections. The research question people bring to it is cognition. The reel says it in one line — a peptide studied for memory and brain connections. Animal and lab studies only. Not proven in people.
Studied for
- Memory and spatial learning in rodent models.
- Synapse and spine growth in laboratory neuron work.
- Proposed mechanisms that have not been established as effects in people, including a 2014 mechanism paper later retracted.
The evidence
Animal only. Supportive findings come from rodent memory models and laboratory neuron work. A 2014 paper that proposed how it works was retracted in 2025 after an investigation found falsified data, and an earlier rat paper still carries a journal expression of concern. A published human trial of dihexa itself has not been shown. A related prodrug, fosgonimeton, was tested in people with Alzheimer’s disease and did not meet its main trial goals. That result is not a test of dihexa, and it is not a reason to treat dihexa as proven. This is not an FDA-approved medicine.
What this page will not do
- “Studied for memory” on the reel is the research question. It is not a result we are claiming in people.
- We do not give a dose, a route, a cycle, or a place to buy it.
- A retracted mechanism paper and an expression of concern are part of the record, not a reason to treat the remaining animal work as settled.
Still open
- Whether a controlled human study of dihexa itself, with a stated size and duration, gets published.
- How to weigh remaining rodent findings after part of the original record was retracted.
- How a related prodrug’s failed Alzheimer’s trial should be described: as context, not as a test of dihexa.
Educational content only. This page does not diagnose, treat, cure, or prevent anything, and it is not a dose. Talk with a licensed physician before starting, stopping, or changing any medication. Library reviewed November 2026.